secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001641172-25-001969
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics closes $3.9M registered direct offering and private placement
--------------------------------------------------------------------------------

- Gross proceeds ~$3.9M from sale of 3.325M shares at $0.65 and pre-funded warrants for 2.728M shares.
- Issued Series G warrants to purchase up to 6.053M shares at $0.6954, exercisable after 6 months for 7.5 years.
- Ladenburg Thalmann placement agent; 8% cash fee + 1% management; received warrants for 302,650 shares at $0.8125.
- Proceeds for working capital and to advance pre-clinical and clinical programs.
- Directors/officers subject to 90-day lock-up; company restricted from further issuances for 75 days (with exceptions).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225001969/0001641172-25-001969-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225001969/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-001969

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer